cytokine-induced memory-like NK cells
Showing 1 - 25 of >10,000
Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia Trial in Saint Louis (biological, drug, procedure)
Not yet recruiting
- Refractory Acute Myeloid Leukemia
- Relapsed Acute Myeloid Leukemia
- Cytokine induced memory-like NK cells
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 30, 2022
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, MDS Trial (biological, drug, procedure)
Withdrawn
- Relapsed Acute Myeloid Leukemia
- +2 more
- Cytokine-induced memory-like NK cells
- +4 more
- (no location specified)
Feb 23, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Cytokine-Induced Memory-like Natural Killer Cells
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 22, 2023
Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)
Recruiting
- Acute Myeloid Leukemia
- CIML-NK Cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 4, 2023
Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,
Not yet recruiting
- Acute Myeloid Leukemia
- +5 more
- Cytokine Induced Memory-like Natural Killer Cells
- Interleukin-2
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)
Recruiting
- Acute Myeloid Leukemia in Children
- CIML NK Cell Infusion
- CD3+ T Cell Product Infusion
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Boston (Interleukin-15
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Recurrent Head and Neck Squamous Cell Carcinoma
- Interleukin-15 Superagonist (N-803)
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 2, 2022
Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)
Not yet recruiting
- Advanced Melanoma
- Metastatic Melanoma
- Memory-like natural killer cells
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 16, 2022
Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)
Recruiting
- Multiple Myeloma
- CIML NK Cells plus KP1237 and low dose IL-2
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 18, 2022
B Cell Leukemia, B Cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Guangzhou (CAR-ITNK cells)
Recruiting
- B Cell Leukemia
- +4 more
- CAR-ITNK cells
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Feb 6, 2021
Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in
Not yet recruiting
- Stage II Fallopian Tube Cancer AJCC v8
- +33 more
- Alpha-type-1 Polarized Dendritic Cells
- Autologous Natural Killer Cell-like CTLs
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 1, 2022
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
Asthma Acute Trial in Marseille (blood sample)
Not yet recruiting
- Asthma Acute
- blood sample
-
Marseille, FranceHôpital NORD - AP-HM, Clinique des bronches, de l'allergie et du
Aug 22, 2023
HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)
Not yet recruiting
- HIV Infection Primary
- Dasatinib 70 mg
- Placebo
-
Badalona, Barcelona, SpainHospital Universitari Germans Trias i Pujol
Mar 9, 2023
Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial (INKmune)
Not yet recruiting
- Cancer
- +2 more
- INKmune
- (no location specified)
Sep 27, 2023
IL- 6 Gene Single Nucleotide Polymorphism asIndicator of
Completed
- Covid19
- interleuken 6 level measurment
- Interleukin-6 Gene-174C detection
-
Tanta, El Gharbyia, EgyptBsant Safwat Kasem
May 1, 2022
Tissue-resident Memory T Cells Expression Among Repigmentation
Completed
- Vitiligo
-
San Luis Potosí, MexicoDermatology Department. Hospital Central "Dr. Ignacio Morones Pr
Aug 16, 2022
Advanced Sarcoma Trial (NKG2D-CAR memory T cell)
Not yet recruiting
- Advanced Sarcoma
- NKG2D-CAR memory T cell
- (no location specified)
Oct 17, 2023
Advanced Liver Cancers Trial (DC-CIK)
Not yet recruiting
- Advanced Liver Cancers
- DC-CIK
- (no location specified)
Nov 11, 2022
Cardiovascular Diseases Trial in Nijmegen (High-fat shake, Reference shake)
Completed
- Cardiovascular Diseases
- High-fat shake
- Reference shake
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Dec 27, 2022
Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose
Not yet recruiting
- Colorectal Cancer Metastatic
- Squamous Cell Carcinoma of Head and Neck
- WU-NK-101 - Dose Escalation
- +3 more
- (no location specified)
Dec 30, 2022
Relapsed Hematologic Malignancy Trial in Bergamo (donor-derived CIK cells)
Recruiting
- Relapsed Hematologic Malignancy
- donor-derived CIK cells
-
Bergamo, ItalyA O Papa Giovanni XXIII
Dec 22, 2021
Acute Myeloid Leukemia Trial (WU-NK-101)
Not yet recruiting
- Acute Myeloid Leukemia
- WU-NK-101
- (no location specified)
Jul 20, 2022
HIV, Healthy Trial in West Haven (Active Delta-9-THC)
Recruiting
- HIV Infections
- Healthy
- Active Delta-9-THC
-
West Haven, ConnecticutVA Connecticut Healthcare System
Aug 2, 2022